INHIBITORY EFFECTS OF SCHISANDRIN A AND SCHISANDRIN B ON CYP3A ACTIVITY

被引:25
|
作者
Li, W. L. [1 ]
Xin, H. W. [1 ]
Su, M. W. [1 ]
Xiong, L. [1 ]
机构
[1] Wuhan Gen Hosp Guangzhou Command, Dept Clin Pharmacol, Wuhan 430070, Peoples R China
关键词
IN-VITRO; P-GLYCOPROTEIN; SPHENANTHERA EXTRACT; MULTIDRUG-RESISTANCE; LIVER-MICROSOMES; ORGANIC-SOLVENTS; MIDAZOLAM; DRUGS; PHARMACOKINETICS; METABOLISM;
D O I
10.1358/mf.2010.32.3.1434161
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Our aim was to investigate the inhibitory effects of schisandrin A and schisandrin Ban cytochrome P450 (CYP3A) activity in rat liver microsomes and the mechanism of this interaction. 1'-Hydroxy midazolam and midazolam 1-hydroxylation catalyzed by CYP3A were analyzed by high performance liquid chromatography (HPLC). Results showed that schisandrin A and schisandrin B inhibited CYP3A activity with IC50 values of 6.60 and 5.51 mu M and K-i Values of 5.83 and 4.24 mu M, respectively. A dilution assay plot of each inhibitor gave a slope value of up to 91% that of the control samples. The inactivation of CYP3A activity by schisandrin A and schisandrin B was found to be both time- and concentration-dependent (schisandrin A: K-i = 4.51 mu M, K-inact = 0.134/min; schisandrin B: K-i = 3.01 mu M, K-inact = 0.112/min). We conclude that the inhibition of CYP3A activity in rat liver microsomes by schisandrin A and schisandrin B is mostly attributed to a mixed noncompetitive and complete inhibition.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [31] In vivo effect of Schisandrin B on cytochrome P450 enzyme activity
    Li, Wei-Liang
    Xin, Hua-Wen
    Yu, Ai-Rong
    Wu, Xiao-Chun
    PHYTOMEDICINE, 2013, 20 (8-9) : 760 - 765
  • [32] Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
    Nishida, Hiroshi
    Tatewaki, Naoto
    Nakajima, Yuki
    Magara, Taku
    Ko, Kam Ming
    Hamamori, Yasuo
    Konishi, Tetsuya
    NUCLEIC ACIDS RESEARCH, 2009, 37 (17) : 5678 - 5689
  • [33] Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humans
    Fujita, K
    Hidaka, M
    Takamura, N
    Yamasaki, K
    Iwakiri, T
    Okumura, M
    Kodama, H
    Yamaguchi, M
    Ikenoue, T
    Arimori, K
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (09) : 1371 - 1373
  • [34] Schisandrin B - A novel inhibitor of P-glycoprotein
    Pan, QR
    Tao, W
    Lu, QH
    Hu, X
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (02) : 406 - 411
  • [35] Schisandrin B regulates lipid metabolism in subcutaneous adipocytes
    Kwan, Hiu Yee
    Wu, Jiahui
    Su, Tao
    Chao, Xiao-Juan
    Yu, Hua
    Liu, Bin
    Fu, Xiuqiong
    Tse, Anfernee Kai Wing
    Chan, Chi Leung
    Fong, Wang Fun
    Yu, Zhi-ling
    SCIENTIFIC REPORTS, 2017, 7
  • [36] EFFECT OF SCHISANDRIN ON SLEEP-WAKE ACTIVITY IN DROSOPHILA
    Huang, L.
    Yu, S.
    Bian, H.
    Li, T.
    SLEEP, 2012, 35 : A5 - A5
  • [37] Beneficial Effects of Schisandrin B on the Cardiac Function in Mice Model of Myocardial Infarction
    Chen, Pengsheng
    Pang, Sisi
    Yang, Naiquan
    Meng, Haoyu
    Liu, Jia
    Zhou, Ningtian
    Zhang, Min
    Xu, Zhihui
    Gao, Wei
    Chen, Bo
    Tao, Zhengxian
    Wang, Liansheng
    Yang, Zhijian
    PLOS ONE, 2013, 8 (11):
  • [38] Schisandrin A and B affect subventricular zone neurogenesis in mouse
    Sun, Yi-Xue
    Cong, Yan-Long
    Liu, Yang
    Jin, Bo
    Si, Lu
    Wang, Ai-Bing
    Cai, Huan
    Che, Guan-Yu
    Tang, Bo
    Wang, Chun-Feng
    Li, Zi-Yi
    Zhang, Xue-Ming
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 : 552 - 559
  • [39] A Comprehensive Review on Schisandrin B and Its Biological Properties
    Nasser, M. I.
    Zhu, Shuoji
    Chen, Chen
    Zhao, Mingyi
    Huang, Huanlei
    Zhu, Ping
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [40] Separation and purification of schisandrin B from Fructus schisandrae
    Luk, Ka F.
    Ko, Kam M.
    Ng, Ka M.
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2008, 47 (12) : 4193 - 4201